Document Detail


Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.
MedLine Citation:
PMID:  19811905     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
AIM: This study investigated the prevalence and predictors of use of complementary and alternative medicine (CAM) in a nationwide inception cohort of Danish women treated for early-stage breast cancer as well as differences in user patterns for individual types of CAM. METHODS: Use of CAM since the time of diagnosis was assessed 12-16 weeks post-surgery for the 3343 women (age 18-70) included in the study (response rate: 68%). Socio-demographic and clinical variables were obtained from national longitudinal registries. RESULTS: 40.1% of the women had used one or more types of CAM. Users were younger than non-users. Age adjusted analyses showed that CAM users were characterised by absence of comorbidity, higher educational level, higher personal income, higher social status, being divorced/separated and living in the metropolitan area of Copenhagen. Multivariate analyses revealed that chemotherapy was the only clinical and treatment-related predictor of CAM use, and that CAM users were more likely to be of normal weight and non-smokers. Of CAM users, 33.7% believed that CAM would have a positive influence upon their breast cancer. Different characteristics distinguished users of individual types of CAM. CONCLUSION: The results of this first nationwide study of utilisation of CAM in breast cancer show that CAM users are healthier and more likely to have higher socio-economic status than non-users. Different user patterns for individual types of CAM may be overlooked, when different types of CAM are treated as one homogeneous category.
Authors:
Christina Gundgaard Pedersen; Søren Christensen; Anders Bonde Jensen; Robert Zachariae
Related Documents :
19912305 - Attitude towards genetic testing for breast cancer susceptibility: a comparison of affe...
11815405 - Women's interest in genetic testing for breast cancer risk: the influence of sociodemog...
15712375 - Thyroid hormone and breast carcinoma. primary hypothyroidism is associated with a reduc...
15253205 - Breast reduction surgery and breast cancer risk: does reduction mammaplasty have a role...
11258215 - The role of angiogenesis in prostate and other urologic cancers: a review.
10493525 - Elevated expression of the cc chemokine regulated on activation, normal t cell expresse...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-10-05
Journal Detail:
Title:  European journal of cancer (Oxford, England : 1990)     Volume:  45     ISSN:  1879-0852     ISO Abbreviation:  Eur. J. Cancer     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-11-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9005373     Medline TA:  Eur J Cancer     Country:  England    
Other Details:
Languages:  eng     Pagination:  3172-81     Citation Subset:  IM    
Affiliation:
Psychooncology Research Unit, Aarhus University Hospital and Aarhus University, Denmark. christina@psy.au.dk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer...
Next Document:  The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled ef...